A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
ALIGN TECHNOLOGY INC operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 4.0B | 4.0B | 4.0B | 3.9B | 3.7B | 4.0B |
| Net Income | 410M | 410M | 421M | 445M | 362M | 772M |
| EPS | $5.65 | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 |
| Free Cash Flow | 491M | 491M | 623M | 608M | 277M | 771M |
| ROIC | 12.6% | 20.6% | 22.7% | 16.2% | 14.4% | 29.2% |
| Gross Margin | 67.2% | 67.2% | 70.0% | 70.1% | 70.5% | 74.3% |
| Debt/Equity | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 546M | 546M | 608M | 643M | 643M | 976M |
| Operating Margin | 13.5% | 13.5% | 15.2% | 16.7% | 17.2% | 24.7% |
| ROE | 10.1% | 10.4% | 10.9% | 12.3% | 10.0% | 21.3% |
| Shares Outstanding | 73M | 73M | 75M | 77M | 78M | 80M |
ALIGN TECHNOLOGY INC passes 6 of 9 quality checks, suggesting mixed fundamentals.
ALIGN TECHNOLOGY INC trades at 30.5x trailing earnings, compared to its 15-year median P/E of 43.7x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 20.7x vs a median of 51.1x. The company's 5-year average ROIC is 20.6% with a gross margin of 70.4%. Total shareholder yield (buybacks) is 3.6%. At current prices, the estimated annualized return to fair value is +5.9%.
ALIGN TECHNOLOGY INC (ALGN) has a current P/E ratio of 30.5, compared to its historical median P/E of 43.7. The stock is currently considered Fair based on its historical valuation range.
ALIGN TECHNOLOGY INC (ALGN) has a 5-year average return on invested capital (ROIC) of 20.6%. This indicates strong capital allocation and a potential competitive advantage.
ALIGN TECHNOLOGY INC (ALGN) has a market capitalization of $13.1B. It is classified as a large-cap stock.
ALIGN TECHNOLOGY INC (ALGN) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 3.55%.
Based on historical P/E analysis, ALIGN TECHNOLOGY INC (ALGN) appears fair. The current P/E of 30.5 is 30% below its historical median of 43.7. The estimated fair value CAGR (P/E method) is -5.8%.
ALIGN TECHNOLOGY INC (ALGN) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, within the Healthcare sector.
ALIGN TECHNOLOGY INC (ALGN) reported annual revenue of $4.0 billion in its most recent fiscal year, based on SEC EDGAR filings.
ALIGN TECHNOLOGY INC (ALGN) has a net profit margin of 10.2%. This is a healthy margin.
ALIGN TECHNOLOGY INC (ALGN) generated $491 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
ALIGN TECHNOLOGY INC (ALGN) has a debt-to-equity ratio of 0.02. This indicates a conservatively financed balance sheet.
ALIGN TECHNOLOGY INC (ALGN) reported earnings per share (EPS) of $5.65 in its most recent fiscal year.
ALIGN TECHNOLOGY INC (ALGN) has a return on equity (ROE) of 10.4%. This indicates moderate shareholder returns.
ALIGN TECHNOLOGY INC (ALGN) has a 5-year average gross margin of 70.4%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 18 years of financial data for ALIGN TECHNOLOGY INC (ALGN), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
ALIGN TECHNOLOGY INC (ALGN) has a book value per share of $55.75, based on its most recent annual SEC filing.